Alpha Cubed Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Alpha Cubed Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,690	Closed	-$218K	–	326
2025 Q1	$218K	Sell	2,690 -3,129	-54%	-$280K	0.01%	273
2024 Q4	$524K	Sell	5,819 -227,549	-98%	-$22M	0.02%	149
2024 Q3	$23.1M	Buy	233,368 +2,176	+0.9%	+$214K	1.03%	35
2024 Q2	$21.4M	Buy	231,192 +42,988	+23%	+$3.85M	1.02%	31
2024 Q1	$17.9M	Buy	188,204 +89,671	+91%	+$8.32M	0.93%	33
2023 Q4	$8.8M	Buy	+98,533	New	+$7.32M	0.49%	57

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Alpha Cubed Investments's XBI Position: Q2 2025 in Review

Alpha Cubed Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 2,690 shares — an estimated $218K sold.

Alpha Cubed Investments first reported a position in XBI in Q4 2023 and held it in 6 quarters. The position peaked at $23.1M in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Alpha Cubed Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Alpha Cubed Investments sold 2,690 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $218K.
Alpha Cubed Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 6 quarters.
Alpha Cubed Investments's State Street SPDR S&P Biotech ETF position peaked at $23.1M in Q3 2024.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Alpha Cubed Investments's 13F filing for Q2 2025, filed 7 Aug 2025.